Evidence map›Paper›PMID 34107257›Full record

ArticleCell reports2021

Ontogenic timing, T cell receptor signal strength, and Notch signaling direct γδ T cell functional differentiation in vivo.

Edward L Y Chen, Christina R Lee, Patrycja K Thompson, David L Wiest, Michele K Anderson, Juan Carlos Zúñiga-Pflücker

Abstract read
In one paragraph

Article in Cell reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. γδ T cells and cancer.The Journal of clinical investigation · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Development of αβ and γδ T Cells in the Thymus and Methods of Analysis.International journal of molecular sciences · 2025
    Review
  8. Article
  9. HEB collaborates with TCR signaling to upregulatebioRxiv : the preprint server for biology · 2025
    Article
  10. T Cell Development: From T-Lineage Specification to Intrathymic Maturation.Advances in experimental medicine and biology · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Edward L Y ChenSunnybrook Research Institute, Toronto, ON, Canada; Department of Immunology, University of Toronto, Toronto, ON, Canada.
Christina R LeeSunnybrook Research Institute, Toronto, ON, Canada.
Patrycja K ThompsonSunnybrook Research Institute, Toronto, ON, Canada.
David L WiestBlood Cell Development and Function, Fox Chase Cancer Center, Philadelphia, PA, USA.
Michele K AndersonSunnybrook Research Institute, Toronto, ON, Canada; Department of Immunology, University of Toronto, Toronto, ON, Canada.
Juan Carlos Zúñiga-PflückerSunnybrook Research Institute, Toronto, ON, Canada; Department of Immunology, University of Toronto, Toronto, ON, Canada. Electronic address: jczp@sri.utoronto.ca.

Funding

The role of TCR, ligand, and signal strength in human γδ T cell developmentP01AI102853 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI Maria Ciofani · 2014 to 2026
$26.3M
CIHR FND-154332NIAID NIH HHS P01 AI102853
6 · The paper itself

Abstract

γδ T cells form an integral arm of the immune system and are critical during protective and destructive immunity. However, how γδ T cells are functionally programmed in vivo remains unclear. Here, we employ RBPJ-inducible and KN6-transgenic mice to assess the roles of ontogenic timing, T cell receptor (TCR) signal strength, and Notch signaling. We find skewing of Vγ1

Indexed as

AnimalsCell DifferentiationHumansInterferon-gammaMiceReceptors, Antigen, T-CellReceptors, NotchSignal TransductionInterferon-gammaReceptors, Antigen, T-CellReceptors, NotchNotch signalingontogenyRBPJ(ind) mouse modelsingle-cell RNA sequencingTCR signalingγδ T cell developmentγδ T cell effector programmingγδ T cell peripheral responses

Identifiers

PMID34107257
PMCPMC8256923

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.